REFERENCES
- Swenson JM, Wallace Jr RJ, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28: 807–811.
- Ingram CW, Tanner DC, Durack DT, Kernodle GW, Corey GR. Disseminated infection with rapidly growing mycobactria. Clin Infect Dis 1993; 16: 463–471.
- Khardory N, Nguyen H, Rosenbaum B, Rolston K, Bodey G. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents. Antimicrob Agents Chemother 1994; 38: 134–137.
- Lessing MP, Walker MM. Fatal pulmonary infection due to Mycobacterium fortuitum. J Clin Pathol 1993; 46 (3): 271–272.
- Jenkins PA. Enfoques nuevos y actuales en el tratamien-to de las infecciones micobacterianas. Bol Union Inter Tuberc Enf Respir 1990; 65(2-3): 83–85.
- Casal M, Rodríguez F, Benavente C. Estudio de la acciOn in vitro de tetraciclinas frente a Mycobacterium fortui-tum y Mycobactrium cbelonei. Laboratorio 1985; 80 (476): 69–75.
- García-Rodríguez JA, Gómez-García AC. In vitro activities of quinolones against mycobacteria. J Antimicrob Chemother 1993; 32 (6): 797–808.
- Maple P, Brumfitt W, Hamilton-Miller JM. A review of the antimicrobial activity of the fluoroquinolones. J Chemother 1990; 2: 280–294.
- Wallace Jr RJ, Nash DR, Steele LC, Steingrube V. Susceptibility testing of slowly growing mycobactria by a microdilution MIC method with 7H9 broth. J Clin Microbiol 1986; 24: 976–981.
- Sanders Jr WE, Hartwing EC, Schneider NJ, Cacciatore R, Valdez H. Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents. Antimicrob Agents Chemother 1977; 12: 295–297.
- Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez Al. In vitro susceptibility of Mycobacterium fortui-turn, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Chemotherapy 1987; 6: 431–433.
- Casal Roman M. Pruebas de resistencia a las drogas. In: Bacteriologia de la tuberculosis y micobacteriosis. Madrid: Editorial AC, 1983: 81–91.
- Casal M, Rodriguez F, Gutierrez J et al. Promising new drugs in the treatment of tuberculosis and mycobacteriosis. J Chemother 1989; 1: 39–45.
- Inderlied CB, Young LS, Yamada JK. Determination of in vitro susceptibility of Mycobacterium avium complex iso-lates to antimycobacterial agents by various methods. Antimicrob Agents Chemother 1987; 1697–1702.
- Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Kallenius G. In vitro synergism between ethambutol and fluo-rinated quinolones against Mycobacterium avium complex. J Antimicrob Chemother 1989; 24: 317–324.
- Swenson JM, Thernsberry C, Silcox V. Rapidly growing Mycobacteria testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982; 22: 186–192.
- Wallace Jr RJ, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium cbelonei on the basis of in vitro susceptibilities. J Infect Dis 1985; 152: 500–514.
- Casal M, Rodriguez F. Estudio de la acciOn in vitro de framicetina y neomicina frente a Mycobacterium fotuitum y Mycobacterium cbelonei. Enf Infect 1983; 1: 201–203.
- Casal M, Rodriguez F. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefoxitin. Tubercle 1982; 63: 125–127.
- Martin Andres A, Luna del Castillo JD. Analisis de la varianza. In: Bioestadistica para las ciencias de la salud. 2nd ed. Madrid: Ediciones Norma S.A., 1989; 380-440.
- Siegel S. El caso de K muestras relacionadas. In: Estadistica no parametrica. Aplicada a las ciencias de la salud. 3rd ed. Mexico D.F.: Editorial Trillas, 1990: 188–203.
- Wallace Jr RJ, Dalovisio JR, Pankey GA. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium cbelonei to antibacterial agents. Antimicrob Agents Chemother 1979; 16: 611–614.